Suxamethonium	suxamethonium	CHEMICALS	O	OTHERS	I
induced	induced	O	O	O	O
prolonged	prolonged	O	O	O	O
apnea	apnea	O	DISEASE	OTHERS	I
in	in	O	O	O	O
a	a	O	O	O	O
patient	patient	O	O	O	O
receiving	receiving	O	O	O	O
electroconvulsive	electroconvulsive	O	O	O	O
therapy	therapy	O	O	O	O
.	.	O	O	O	O

Suxamethonium	suxamethonium	CHEMICALS	O	OTHERS	I
causes	causes	O	O	O	O
prolonged	prolonged	O	O	O	O
apnea	apnea	O	DISEASE	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
in	in	O	O	O	O
whom	whom	O	O	O	O
pseudocholinesterase	pseudocholinesterase	O	O	O	O
enzyme	enzyme	O	O	O	O
gets	gets	O	O	O	O
deactivated	deactivated	O	O	O	O
by	by	O	O	O	O
organophosphorus	organophosphorus	O	O	OTHERS	I
(	(	O	O	OTHERS	I
OP	op	O	O	OTHERS	I
)	)	O	O	OTHERS	I
poisons	poisons	O	O	OTHERS	I
.	.	O	O	O	O

Here	here	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
present	present	O	O	O	O
a	a	O	O	O	O
similar	similar	O	O	O	O
incident	incident	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
severely	severely	O	O	O	O
depressed	depressed	O	DISEASE	OTHERS	I
patient	patient	O	O	O	O
who	who	O	O	O	O
received	received	O	O	O	O
electroconvulsive	electroconvulsive	O	O	O	O
therapy	therapy	O	O	O	O
(	(	O	O	O	O
ECT	ect	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Prolonged	prolonged	O	O	O	O
apnea	apnea	O	DISEASE	OTHERS	I
in	in	O	O	O	O
our	our	O	O	O	O
case	case	O	O	O	O
ensued	ensued	O	O	O	O
because	because	O	O	O	O
the	the	O	O	O	O
information	information	O	O	O	O
about	about	O	O	O	O
suicidal	suicidal	O	O	O	O
attempt	attempt	O	O	O	O
by	by	O	O	O	O
OP	op	O	O	OTHERS	I
compound	compound	O	O	OTHERS	I
was	was	O	O	O	O
concealed	concealed	O	O	O	O
from	from	O	O	O	O
the	the	O	O	O	O
treating	treating	O	O	O	O
team	team	O	O	O	O
.	.	O	O	O	O

